References UK clinical guidance from the NHS, the British HIV Association (BHIVA), and the British Association for Sexual Health and HIV (BASHH). Last updated: April 2026.
Stopping HIV treatment — even for a short break — can damage your long-term health. Large studies have shown that treatment interruptions are linked to more infections, more cardiovascular problems and a higher risk of death compared to staying on continuous therapy. Modern HIV treatment is simple, usually a single daily tablet, and is designed to be taken lifelong.
Here’s what the evidence says and why your HIV team will always advise against unplanned treatment breaks.
Order a discreet home HIV test
What the Research Showed
The SMART study (Strategies for Management of Antiretroviral Therapy) was a large international trial that compared continuous ART with a CD4-guided interrupted strategy. People on the interrupted strategy took treatment breaks when their CD4 count was above 350 and restarted when it dropped below 250.
The results were clear: people on interrupted therapy had more opportunistic infections, more serious non-AIDS events like heart attacks and strokes, and higher mortality than those on continuous treatment. The trial was stopped early because the harm was so obvious.
Why Treatment Breaks Cause Harm
- HIV rebounds quickly — within weeks, viral load climbs back up
- Inflammation returns — raising cardiovascular risk
- CD4 count drops — the immune system weakens
- Risk of drug resistance — especially if breaks are frequent or unplanned
- Risk of passing HIV on — rising viral load ends U=U protection
Common Reasons People Consider Stopping
| Reason | Better Approach |
|---|---|
| Side effects | Ask your HIV team about switching — many alternatives exist |
| Pill fatigue or not wanting a daily reminder | Ask about long-acting injectable options |
| Travelling and running out of supply | Get a longer prescription before you travel |
| Cost or supply issues | ART is free on the NHS — speak to your clinic |
| Depression or low motivation | Ask for mental health support — it’s treatable |
| Feeling well and wanting a break | Talk to your team — don’t stop on your own |
If You’ve Already Stopped
If you’ve stopped ART, for any reason, contact your HIV clinic as soon as possible. They can:
- Test your CD4 and viral load
- Check for resistance before restarting
- Choose the right regimen to get you back on track
- Help you understand what happened and plan to prevent it recurring
There is no judgment in an HIV clinic about missed treatment. Clinics are used to helping people restart and get back to being undetectable.
If You’re Struggling with Treatment
Talk to your HIV team. Options might include:
- Switching to a different daily tablet with fewer side effects
- Long-acting injectable ART given every 1-2 months
- Mental health support
- Peer support from others living with HIV
- Practical help with reminders, routines and supplies
Read more: What is HIV? | HIV and the immune system | Biktarvy for HIV
Frequently Asked Questions
Will a few days off treatment cause harm?
A single missed dose or two is unlikely to cause lasting harm, though it briefly raises viral load. Longer or repeated breaks are more concerning. Always speak to your HIV team if you can’t take your medication.
Are structured treatment breaks ever used?
Not routinely. Research ruled them out as a strategy more than a decade ago. Continuous treatment is the standard for everyone.
Long-term undetectable status doesn’t mean you can stop safely. HIV is still present in hidden reservoirs and will rebound within weeks of stopping.
Related reading
- Injectable HIV Treatment: Everything You Need to Know
- Are HIV Tests Accurate If You're on PrEP, PEP or ART?
- CD4/CD8 Ratio: What It Means and Why It Matters
- CD4 Counts Explained: What Your Numbers Mean
- Changing HIV Treatment: When, Why and How
Sources
- NHS — Sexual health conditions
- BASHH — UK clinical guidelines for STI management
- British HIV Association (BHIVA) — HIV treatment guidelines
- Terrence Higgins Trust — sexual health information
- UK Health Security Agency — STI surveillance data
Steve Page is a recognised expert on Sexually Transmitted Diseases (STDs) and STD treatments, having published numerous articles in peer-reviewed journals and presented his research at conferences around the world. He has an in-depth understanding of the latest medical research on STDs, and is an advocate for the development of new treatments and protocols to improve the health of those affected. In addition to his research, he has dedicated his career to understanding the causes and symptoms of STDs, as well as how to best treat those impacted.
